Healthcare Equipment and Supplies
Company Overview of TriVascular Technologies, Inc.
TriVascular Technologies, Inc., a medical device company, develops and commercializes technologies to advance minimally invasive treatment of abdominal aortic aneurysms (AAA). The company offers Ovation System, a stent graft platform for the treatment of AAA through minimally invasive endovascular aortic repair. Its ovation system components include arotic body, iliac limbs, and fill polymer. The company markets and sells its products through direct sales organizations in the United States, Germany, the United Kingdom, the Netherlands, and Canada, as well as through distributors or agents in other markets. TriVascular Technologies, Inc. was incorporated in 2007 and is headquartered in Santa ...
3910 Brickway Boulevard
Santa Rosa, CA 95403
Founded in 2007
Key Executives for TriVascular Technologies, Inc.
Chairman, Chief Executive Officer and President
Total Annual Compensation: $450.0K
Co-Founder and Chief Technology Officer
Total Annual Compensation: $296.3K
Chief Financial Officer and Principal Accounting Officer
Total Annual Compensation: $356.2K
Compensation as of Fiscal Year 2014.
TriVascular Technologies, Inc. Key Developments
TriVascular Technologies, Inc.(NasdaqGS:TRIV) dropped from NASDAQ Composite Index
Feb 4 16
TriVascular Technologies, Inc. will be removed from Nasdaq Composite Index.
TriVascular Technologies, Inc. Amends and Restates Certificate of Incorporation
Feb 3 16
TriVascular Technologies, Inc. amended and restated Certificate of Incorporation. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, the company's certificate of incorporation was amended and restated in its entirety. Pursuant to the terms of the Merger Agreement, the bylaws of Merger Sub as in effect at the effective time of the Merger became the bylaws of TriVascular.
TriVascular Technologies, Inc., Special/Extraordinary Shareholders Meeting, Feb 03, 2016
Jan 26 16
TriVascular Technologies, Inc., Special/Extraordinary Shareholders Meeting, Feb 03, 2016, at 09:00 Pacific Standard Time. Location: offices of Arnold & Porter LLP, Three Embarcadero Center San Francisco, CA 94111 United States Agenda: To consider and vote upon, among other things, a proposal to adopt the Agreement and Plan of Merger.
Similar Private Companies By Industry
Recent Private Companies Transactions
October 26, 2015
August 18, 2015
August 4, 2015